NCT03025919

Brief Summary

Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

January 11, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 20, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

May 8, 2017

Status Verified

May 1, 2017

Enrollment Period

5 months

First QC Date

January 11, 2017

Last Update Submit

May 3, 2017

Conditions

Type II Diabetes Mellitus

Keywords

Advanced glycation end-productGlycosuria

Outcome Measures

Primary Outcomes (1)

  • area under the ROC curve

    area under the ROC curve of different method of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

    6 months

Secondary Outcomes (1)

  • sensitivity and specificity of screening

    6 months

Eligibility Criteria

Age12 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Natural Chinese population

You may qualify if:

  • \~70 year old urban and rural residents;
  • Volunteer to participate in this study and sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, Southeast University

Nanjing, Jiangsu, China

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Glycosuria

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director physician

Study Record Dates

First Submitted

January 11, 2017

First Posted

January 20, 2017

Study Start

January 1, 2017

Primary Completion

June 1, 2017

Study Completion

December 1, 2017

Last Updated

May 8, 2017

Record last verified: 2017-05

Locations

CN(1)